Table 2.
Comparison of surgical outcomes for vitrectomy with or without external subretinal fluid drainage.
External drainage Yes (N = 14) | External drainage No (N = 12) | P value | |
---|---|---|---|
Age | 8.4 ± 6.1 | 9.9 ± 4.5 | 0.48 |
Sex (Male:Female) | 13:1 | 12:0 | 0.26 |
Stage (3A:3B:4) | 0:11:3 | 5:7:0 | 0.01 |
Initial VA (logMAR) | 2.3 ± 0.7 | 1.4 ± 1.0 | 0.01 |
Final VA (logMAR) | 2.0 ± 0.9 | 1.1 ± 0.9 | 0.02 |
Post-op ablation therapy | 1.1 ± 1.5 | 0.8 ± 1.3 | 0.80 |
Post-op IVB | 0.2 ± 0.4 | 0.9 ± 1.2 | 0.08 |
Total number of surgeries | 2.6 ± 1.7 | 1.8 ± 1.1 | 0.16 |
Complete SRF resolution | 14/14 (100%) | 9/12 (75%) | 0.03 |
Complications | 5/14 (36%) | 2/12 (17%) | 0.27 |
Follow-up period (Month) | 46.7 ± 40.6 | 35.2 ± 9.5 | 0.38 |
IVB, intravitreal injection of bevacizumab; SRF, subretinal fluid.
Significant P values in bold.